These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 8804808)

  • 1. An enzyme immunoassay for serum and urinary levonorgestrel in human and non-human primates.
    Munro CJ; Laughlin LS; VonSchalscha T; Baldwin DM; Lasley BL
    Contraception; 1996 Jul; 54(1):43-53. PubMed ID: 8804808
    [TBL] [Abstract][Full Text] [Related]  

  • 2. First week drug concentrations in women with levonorgestrel rod or Norplant capsule implants.
    Sivin I; Lähteenmäki P; Mishell DR; Alvarez F; Diaz S; Ranta S; Grozinger C; Lacarra M; Brache V; Pavez M; Nash H; Stern J
    Contraception; 1997 Nov; 56(5):317-21. PubMed ID: 9437561
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sex hormone binding globulin and free levonorgestrel index in the first week after insertion of Norplant implants.
    Alvarez F; Brache V; Tejada AS; Cochon L; Faundes A
    Contraception; 1998 Oct; 58(4):211-4. PubMed ID: 9866001
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Serum levels of levonorgestrel during long-term use of Norplant].
    Du M; Shao Q; Zhou X
    Zhonghua Fu Chan Ke Za Zhi; 1999 Jun; 34(6):363-5. PubMed ID: 11360617
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of levonorgestrel and ethinylestradiol in 14 women during three months of treatment with a tri-step combination oral contraceptive: serum protein binding of levonorgestrel and influence of treatment on free and total testosterone levels in the serum.
    Kuhnz W; Staks T; Jütting G
    Contraception; 1994 Dec; 50(6):563-79. PubMed ID: 7705098
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interrelationship of serum levonorgestrel and sex hormone-binding globulin levels following vaginal and oral administration of combined steroid contraceptive tablets.
    Abdalla KA; Shabaan MM; Stanczyk FZ
    Contraception; 1992 Feb; 45(2):111-8. PubMed ID: 1559334
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Levonorgestrel implants (Norplant II) for male contraception clinical trials: combination with transdermal and injectable testosterone.
    Gonzalo IT; Swerdloff RS; Nelson AL; Clevenger B; Garcia R; Berman N; Wang C
    J Clin Endocrinol Metab; 2002 Aug; 87(8):3562-72. PubMed ID: 12161475
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of levonorgestrel-releasing intrauterine device on hormonal profile and menstrual pattern after long-term use.
    Xiao B; Zeng T; Wu S; Sun H; Xiao N
    Contraception; 1995 Jun; 51(6):359-65. PubMed ID: 7554977
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin sensitivity is unaltered by the use of the Norplant subdermal implant contraceptive.
    Koopersmith TB; Lobo RA
    Contraception; 1995 Mar; 51(3):197-200. PubMed ID: 7621688
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum levonorgestrel levels and endometrial thickness during extended use of the levonorgestrel-releasing intrauterine system.
    Hidalgo MM; Hidalgo-Regina C; Bahamondes MV; Monteiro I; Petta CA; Bahamondes L
    Contraception; 2009 Jul; 80(1):84-9. PubMed ID: 19501221
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative levonorgestrel plasma level measurements in patients with regular and prolonged use of the levonorgestrel-releasing intrauterine system.
    Seeber B; Ziehr SC; Gschlieβer A; Moser C; Mattle V; Seger C; Griesmacher A; Concin N; Concin H; Wildt L
    Contraception; 2012 Oct; 86(4):345-9. PubMed ID: 22402256
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immediate postpartum insertion of the norplant contraceptive device.
    Molland JR; Morehead DB; Baldwin DM; Castracane VD; Lasley B; Bergquist CA
    Fertil Steril; 1996 Jul; 66(1):43-8. PubMed ID: 8752609
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Levonorgestrel concentrations during use of levonorgestrel rod (LNG ROD) implants.
    Sivin I; Lähteenmäki P; Ranta S; Darney P; Klaisle C; Wan L; Mishell DR; Lacarra M; Viegas OA; Bilhareus P; Koetsawang S; Piya-Anant M; Diaz S; Pavez M; Alvarez F; Brache V; LaGuardia K; Nash H; Stern J
    Contraception; 1997 Feb; 55(2):81-5. PubMed ID: 9071516
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of levonorgestrel and ethinylestradiol in 9 women who received a low-dose oral contraceptive over a treatment period of 3 months and, after a wash-out phase, a single oral administration of the same contraceptive formulation.
    Kuhnz W; al-Yacoub G; Fuhrmeister A
    Contraception; 1992 Nov; 46(5):455-69. PubMed ID: 1458892
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enzyme immunoassay for specific determination of the synthetic estrogen, ethynyl estradiol, in plasma.
    Turkes A; Dyas J; Read GF; Riad-Fahmy D
    Clin Chem; 1981 Jun; 27(6):901-5. PubMed ID: 7016369
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum and peritoneal fluid levels of levonorgestrel in women with endometriosis who were treated with an intrauterine contraceptive device containing levonorgestrel.
    Lockhat FB; Emembolu JE; Konje JC
    Fertil Steril; 2005 Feb; 83(2):398-404. PubMed ID: 15705381
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development, validation and utilization of a highly sensitive LC-MS/MS method for quantification of levonorgestrel released from a subdermal implant in human plasma.
    Cirrincione LR; Penchala SD; Scarsi KK; Podany AT; Winchester LC; Back DJ; Khoo SH; Fletcher CV; Siccardi M; Else LJ
    J Chromatogr B Analyt Technol Biomed Life Sci; 2018 May; 1084():106-112. PubMed ID: 29579732
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The interaction between sex hormone binding globulin and levonorgestrel released from Norplant, an implantable contraceptive.
    Affandi B; Cekan SZ; Boonkasemsanti W; Samil RS; Diczfalusy E
    Contraception; 1987 Feb; 35(2):135-45. PubMed ID: 3109803
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A prototype for ovulation detection: pros and cons.
    Lasley BL; Shideler SE; Munro CJ
    Am J Obstet Gynecol; 1991 Dec; 165(6 Pt 2):2003-7. PubMed ID: 1755459
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discordance between self-reported contraceptive use and detection of exogenous hormones among Malawian women enrolling in a randomized clinical trial.
    Nwaohiri AN; Tang JH; Stanczyk F; Chinula L; Hurst S; Davis NL; Tegha G; Haddad L; Kourtis AP
    Contraception; 2018 Apr; 97(4):354-356. PubMed ID: 29246819
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.